microdosing glp-1 agonists of GLP-1's / Wellness Services / Services Microdosing Semaglutide: Weight Loss Plus

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

Full dose or microdose

Are GLP-1 & weight loss drugs covered by insurance

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety